Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.06% |
| 2 | Consumer Discretionary | 1.41% |
| 3 | Healthcare | 0.83% |
| 4 | Financials | 0.79% |
| 5 | Industrials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFS
1701
PUT
DELISTED
Discover Financial Services
DFS
| $22M | ﹤0.01% |
195,300
-321,700
| -62% | -$29.7M |
|
1702
Zions Bancorporation
ZION
$9.86B
| $21.9M | ﹤0.01% |
498,937
+343,931
| +222% | +$12.4M |
|
1703
Noble Corp
NE
$7.32B
| $21.9M | ﹤0.01% |
454,374
+142,128
| +46% | +$6.64M |
|
1704
PUT
iShares MSCI Mexico ETF
EWW
$1.81B
| $21.9M | ﹤0.01% |
322,300
-222,400
| -41% | -$13.4M |
|
1705
PUT
Tenet Healthcare
THC
$21.9B
| $21.9M | ﹤0.01% |
289,300
+91,400
| +46% | +$5.79M |
|
1706
PUT
AGNC Investment
AGNC
$12.9B
| $21.9M | ﹤0.01% |
2,228,300
-180,200
| -7% | -$1.58M |
|
1707
Quanta Services
PWR
$90.8B
| $21.9M | ﹤0.01% |
101,288
-19,893
| -16% | -$3.68M |
|
1708
CALL
Banco Santander
SAN
$213B
| $21.8M | ﹤0.01% |
5,271,800
+37,100
| +0.7% | +$145K |
|
|
IMGN
1709
DELISTED
Immunogen Inc
IMGN
| $21.8M | ﹤0.01% |
736,034
-238,853
| -25% | -$4.76M |
|
1710
CALL
Aramark
ARMK
$15.6B
| $21.8M | ﹤0.01% |
775,700
+107,714
| +16% | +$2.92M |
|
1711
Generac Holdings
GNRC
$11.9B
| $21.8M | ﹤0.01% |
168,643
-60,350
| -26% | -$6.62M |
|
1712
CALL
Sanofi
SNY
$110B
| $21.8M | ﹤0.01% |
438,200
+220,800
| +102% | +$10.8M |
|
1713
Ingersoll Rand
IR
$30.5B
| $21.8M | ﹤0.01% |
281,676
-169,062
| -38% | -$11.6M |
|
|
EA
1714
DELISTED
Electronic Arts
EA
| $21.8M | ﹤0.01% |
159,028
-220,703
| -58% | -$29.2M |
|
1715
PUT
Albertsons Companies
ACI
$6.01B
| $21.8M | ﹤0.01% |
945,900
+184,800
| +24% | +$4.08M |
|
1716
CALL
Exelon
EXC
$45.7B
| $21.7M | ﹤0.01% |
604,600
-27,400
| -4% | -$1.06M |
|
1717
HCA Healthcare
HCA
$92.8B
| $21.7M | ﹤0.01% |
80,187
-43,885
| -35% | -$10.8M |
|
1718
CALL
Neurocrine Biosciences
NBIX
$15.6B
| $21.7M | ﹤0.01% |
164,700
-21,100
| -11% | -$2.43M |
|
1719
CALL
Ionis Pharmaceuticals
IONS
$10.6B
| $21.7M | ﹤0.01% |
428,700
+173,500
| +68% | +$8.31M |
|
1720
CALL
Global Ship Lease
GSL
$1.63B
| $21.6M | ﹤0.01% |
1,091,400
-98,100
| -8% | -$1.79M |
|
1721
PUT
SAP
SAP
$250B
| $21.6M | ﹤0.01% |
139,800
+6,400
| +5% | +$926K |
|
1722
Pinduoduo
PDD
$125B
| $21.6M | ﹤0.01% |
147,641
+96,694
| +190% | +$11.7M |
|
1723
PUT
Bank OZK
OZK
$5.36B
| $21.6M | ﹤0.01% |
433,500
-264,500
| -38% | -$10.9M |
|
|
SKX
1724
PUT
DELISTED
Skechers
SKX
| $21.6M | ﹤0.01% |
346,500
-98,900
| -22% | -$5.33M |
|
1725
Kinder Morgan
KMI
$68.9B
| $21.6M | ﹤0.01% |
1,224,241
-513,884
| -30% | -$8.76M |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Technology at 2.1% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.